Dianthus Therapeutics is based in New York, NY. It has raised $100M in total funding. Latest round: Series A.
Dianthus Therapeutics is based in New York, NY. Dianthus Therapeutics has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in May 2022. The round record for Dianthus Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include 5AM Ventures, Avidity Partners, Fidelity Management & Research Company, Wedbush Healthcare Partners, Fairmount, Tellus BioVentures and 1 others. 7 distinct backers are named across the disclosed rounds.
Round data for Dianthus Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in New York and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026